Speeding innovation for industry
Article | Diagnosis
Technologies for healthcare
CEA Tech institute Leti pioneered DNA chips for diagnostics two decades ago. Today, the institute possesses unrivalled know-how in MEMS and NEMS for healthcare applications. Leti’s broad knowledge of 200 mm silicon technology, lensless imaging, microfluidics, biochemical sensors, and signal processing position the institute to offer its partners—manufacturers and clinical practitioners—integrated, miniaturized solutions in the form of labs-on-chip. The institute’s experience with biomaterials for healthcare has led to the development of nanovectors for targeted drug delivery and enhancements to other therapies (cell encapsulation, wound monitoring, etc.).
Several startups have been created to develop and commercialize the institute’s portable microsystems, in particular in the field of medical diagnostics.
ALL TECHNOLOGY PLATFORMS
A cohort of around 10,000 patients on blood thinners will soon have access to an out-of-hospital care pathway for their regular monitoring needs. Avalun is helping create the new pathway with its connected miniaturized lab.
The EU M.O.T.I.O.N project is investigating solutions to improve the quality of life of children with neuromotor disorders. A bionic rehabilitation technology will be developed, tested, and implemented under this EU-funded initiative.
Researchers at Leti, a CEA Tech institute, came up with a novel way to manipulate microscopic objects: evanescent acoustic waves. Their findings were published in Nature Communications Physics and the technique could have a bright future in biotechnology.
The PEP’s automated biological sample preparation kit has been released. The result of three years of research and development backed by the people at Y.SPOT and financed by the Carnot Network, the kit won an “Innovation Best Team Practices” award in the Products and Services category from the Paris Innovation Directors’ Club on September 5, 2019.
In research conducted under the Biomargin project, a series of reliable, robust biological signatures were identified to predict the risk of rejection after a kidney transplant. The biomarkers will help doctors make the best possible decisions for their patients.
How to collaborate with CEA Tech teams ?
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.